COMMUNIQUÉS West-GlobeNewswire

ProDentim Reviews (Complaints & Side Effects) – 2025 Update: Real Users Reveal the Truth About Benefits and Results
01/04/2025
Is ProDentim the best probiotic dental supplement for improving oral microbiome balance and overall dental health? Discover ProDentim reviews, user results, complaints, ingredients, and find where to buy it safely. [...]
Buy Clenbuterol: Best Legal Clenbuterol Steroids For Weight Loss & Clen Cutting Cycle For Sale From CrazyBulk
01/04/2025
NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Clenbuterol is used by both men and women to lose weight, raises metabolic rate and aids in fat reduction. Taking clenbuterol may also help users keep lean muscle and [...]
Anavar For Women: Dosage, Pills (Before & After Cycle Results) – Buy Legal Anavar Steroid For Female From CrazyBulk
01/04/2025
NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- If you are a female individual contemplating the usage of steroids to support your weight management and health and fitness objectives, Anavar may have emerged as a viable [...]
Zelluna ASA [ZLNA]: Ex reverse share split today
01/04/2025
Oslo, Norway, 1 April 2025 Issuer name: Zelluna ASA Ex. date: 1 April 2025 Type of corporate action: Reverse share split Other information: Reverse split ratio – ten (10) old shares give one (1) new share. New par value [...]
ONWARD Medical Reports Full Year 2024 Financial and Operating Results and Shares 2025 Year-to-Date Highlights
01/04/2025
Received FDA authorization and recorded first commercial sales of ARC-EX System Secured strategic investment from Ottobock and extended cash runway for two years Gained exclusive rights to premier brain-computer [...]
ONWARD Medical publie ses résultats financiers et opérationnels pour l’exercice 2024 et partage ses faits marquants du début de l’année 2025
01/04/2025
Obtention de l’autorisation de la FDA et premières ventes commerciales du système ARC-EX Investissement stratégique d’Ottobock et extension de la visibilité financière sur deux ans Obtention de droits exclusifs sur une [...]
Renowned Biomedical Scientist Franco Cavaleri Challenges Conventional Alzheimer's Theories in Groundbreaking Study
01/04/2025
VANCOUVER, British Columbia, March 31, 2025 (GLOBE NEWSWIRE) -- Franco Cavaleri, B.Sc., Ph.D.c, a distinguished biomedical research scientist and CEO of Biologic Pharmamedical Research and Manufacturing , has published [...]
Avicanna Announces Late Filing of Financial Statements and Application for Management Cease Trade Order
01/04/2025
Auditor Licensing & Personnel Issues Delays Issuance of Audit Opinion The Company expects to file within 2 weeks TORONTO, March 31, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or “ Company ”) (TSX: AVCN) ( [...]
Scientific Industries Reports Financial Results for Fiscal Year Ended December 31, 2024 and Launches DOTS MPS for Cell Culture Biopharma Market
31/03/2025
BIOPROCESSING OPERATIONS: 24% REVENUE GROWTH DRIVEN BY NEWLY LAUNCHED PRODUCTS OPERATIONAL EFFICIENCIES CUT TOTAL NET LOSSES BY 29% LAUNCHED NEW STATE OF THE ART VIVID WORKSTATION Investor Call to be held Tuesday, April [...]
Glucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights
31/03/2025
Transformational 2024: successfully advanced from preclinical to clinical stage company Strengthened leadership team to drive growth and advance clinical development Investigational Device Exemption (IDE) approval for [...]
Total number of shares and voting rights in Zealand Pharma as of March 31, 2025
31/03/2025
Company announcement – No. 8 / 2025 Total number of shares and voting rights in Zealand Pharma as of March 31, 2025 Copenhagen, Denmark, March 31, 2025 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: [...]
Bavarian Nordic Receives U.S. FDA Approval of Freeze-Dried Smallpox and Mpox Vaccine
31/03/2025
COPENHAGEN, Denmark, March 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced that the U.S. Food and Drug Administration (FDA) has approved the freeze-dried formulation of JYNNEOS ® (Smallpox and Mpox Vaccine, [...]
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
31/03/2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of [...]
Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement
31/03/2025
SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of targeted [...]
ANI Pharmaceuticals to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference
31/03/2025
PRINCETON, N.J., March 31, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, will host a fireside chat [...]
VAXIL’s Annual and Special Shareholders Meeting
31/03/2025
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, March 31, 2025 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“ Vaxil ” or the “ Company ”) (TSX VENTURE: VXL), announces that at the Company's Annual and [...]
FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update
31/03/2025
Proprietary master cell bank of fibroblast-based spheroids product candidate, CYWC628, completed in accordance with Good Manufacturing Practices after successfully passing all required safety testing Preparations for [...]
Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update
31/03/2025
NEW HOPE, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients [...]
Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update
31/03/2025
Year over year product revenue increased 26% Operating expenses declined 21% and year over year operating loss decreased 35% Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo., March 31, 2025 (GLOBE [...]

Pages